When Enough Is Enough: Decision Criteria for Moving a Known Drug into Clinical Testing for a New Indication in the Absence of Preclinical Efficacy Data. - Pulley JM; Jerome RN; Zaleski NM; Shirey-Rice JK; Pruijssers AJ; Lavieri RR; Chettiar SN; Naylor HM; Aronoff DM; Edwards DA; Niswender CM; Dugan LL; et al. (Assay and drug development technologies, 2017)